Zobrazeno 1 - 10
of 196
pro vyhledávání: '"K Kiel"'
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Objective This study aimed to evaluate the expression level of anti-apoptotic Bcl-2 family proteins in B and T cells in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in relation to disease activity and the ef
Externí odkaz:
https://doaj.org/article/e075aa1cb99049cc9e2351fbe28982c3
Publikováno v:
Minerals Engineering. 101:58-70
At the Kipoi copper/cobalt operation in the Democratic Republic of the Congo, the coarse fraction of the floating product from a heavy media separation (HMS) plant is being heap leached. The macro-scale performance observed in laboratory columns is c
Autor:
Jennifer Young, David J. Sher, Mary J. Fidler, Marta Batus, Philip Bonomi, K Kiel, Virag Dandekar
Publikováno v:
American Journal of Clinical Oncology. 38:605-609
Introduction To assess the efficacy and tolerability of palliative split-course concurrent thoracic chemoradiotherapy (CRT) in patients with incurable locally advanced and metastatic non-small cell lung cancer. Methods All patients with incurable non
Publikováno v:
Decision Analytics and Optimization in Disease Prevention and Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c366b84b12dd62bd7be6bbf4e25979
https://doi.org/10.1002/9781118960158.ch12
https://doi.org/10.1002/9781118960158.ch12
Publikováno v:
Medical physics. 39(6Part16)
Purpose: High dose rate (HDR) volumetric brachytherapy is an effective method of treating advanced cervix carcinoma. Local failure is associated with multiple factors including higher maximal standardized uptake value (SUV) values in fluorodeoxygluco
Autor:
K Kiel, William Small, Tamer Refaat, Minesh P. Mehta, Mehee Choi, William J. Gradishar, Germaine Gaber
Publikováno v:
American Journal of Clinical Oncology. 37:480-485
Purpose Metastatic breast cancer (MBC) remains an incurable disease despite advances in treatment modalities. In 2008, the FDA approved bevacizumab with paclitaxel for the initial treatment of HER2-negative MBC. The approval was then officially revok
Autor:
K Kiel, Julius V. Turian, Shalini Garg, David J. Sher, Mary J. Fidler, Philip Bonomi, Marta Batus, Benjamin T. Gielda
Publikováno v:
Practical Radiation Oncology. 4:342-348
Purpose Chemoradiation therapy (CRT) is the core treatment of locally advanced non-small cell lung cancer (LA-NSCLC), but potential toxicities limit radiation therapy dose. These toxicities, plus the advent of increasingly conformal radiation therapy
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:e658-e659
Publikováno v:
Brachytherapy. 17:S17-S18
Publikováno v:
Interfaces. 43:462-476
Cervical cancer has a high mortality rate (approximately 35 percent) in the United States and is difficult to treat successfully. One promising treatment is high-dose-rate brachytherapy, which entails delivering high-dose radiation to the tumor via t